KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Non-Current Deferred Tax Liability (2016 - 2026)

Pfizer has reported Non-Current Deferred Tax Liability over the past 18 years, most recently at $2.4 billion for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 6.82% to $2.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Mar 2026, up 6.82% year-over-year, with the annual reading at $2.4 billion for FY2025, 81.56% down from the prior year.
  • Non-Current Deferred Tax Liability was $2.4 billion for Q1 2026 at Pfizer, roughly flat from $2.4 billion in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $13.0 billion in Q4 2024 and troughed at $558.0 million in Q3 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $2.2 billion (2024), against an average of $2.7 billion.
  • Year-over-year, Non-Current Deferred Tax Liability crashed 93.28% in 2023 and then soared 1934.84% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $9.5 billion in 2022, then crashed by 93.28% to $640.0 million in 2023, then soared by 1934.84% to $13.0 billion in 2024, then tumbled by 81.56% to $2.4 billion in 2025, then rose by 0.46% to $2.4 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Non-Current Deferred Tax Liability are $2.4 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.5 billion (Q3 2025).